Doximity (NYSE:DOCS) reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools.
Adjusted EBITDA totaled $75 million,
Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 7.3% year on year to $156....
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out
Medical professional network Doximity (NYSE:DOCS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to ...
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out
Medical professional network Doximity (NYSE:DOCS) will be announcing earnings results this Thursday afternoon. Here’s what investors should know. Doximity me...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
What a brutal six months it’s been for Doximity. The stock has dropped 48.2% and now trades at $21.15, rattling many shareholders. This was partly driven by ...
What Happened? A number of stocks fell in the afternoon session after sentiment continued to weaken as tech stocks faced a dual headwind of deteriorating mac...
Looking back on vertical software stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers. Sof...
What Happened? A number of stocks fell in the afternoon session after President Trump declared the Iran ceasefire "over" and threatened renewed strikes, send...
What Happened? A number of stocks jumped in the afternoon session after Guggenheim's John DiFucci upgraded both Salesforce and ServiceNow to Buy, arguing the...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
What Happened? A number of stocks jumped in the afternoon session after Snowflake's impressive earnings results provided clearer evidence that the "SaaSpocal...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Curious about Doximity's potential in the evolving healthcare tech landscape? Tune in as our experts rate its business strength and future growth prospects!
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
